Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 1 open-market purchase and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Lipocine Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 17 | 19 | +2 |
| Shares | 486.7K | 517.5K | +30.8K (+6.3%) |
| Value | $2.38M | $1.65M | −$729.4K (−30.7%) |
New holders (2)
Institutions that held Lipocine Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SBI Securities Co., Ltd. | 67 | $213 | 0.00% |
| Tidemark, LLC | 59 | $188 | 0.00% |
Sold out (0)
Institutions that held Lipocine Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
None.